Veradigm Inc. (MDRX)

Market Cap	866.76M +5.2%
Revenue (ttm)	594.41M -60.9%
Net Income	-291.54M
EPS	-2.70
Shares Out	170.29M
PE Ratio	n/a
Forward PE	20.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	271
Open	4.60
Previous Close	5.00
Day's Range	4.60 - 5.09
52-Week Range	3.25 - 6.00
Beta	0.51
Analysts	Buy
Price Target	6.50 (+27.7%)
Earnings Date	Sep 11, 2026

About Veradigm

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EH...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1986
• Employees: 2,300
• Stock Exchange: OTCMKTS
• Ticker Symbol: MDRX

Analyst Summary

According to 2 analysts, the average rating for MDRX stock is "Buy." The 12-month stock price target is $6.50, which is an increase of 27.70% from the latest price.

Price Target

$6.50

(27.70% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error